| scholarly article | Q13442814 |
| P2093 | author name string | Emil Martin | |
| Iraida Sharina | |||
| Harri Härmä | |||
| Kari Kopra | |||
| P2860 | cites work | NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential | Q24656131 |
| Extending the translational potential of targeting NO/cGMP-regulated pathways in the CVS | Q27021649 | ||
| Phosphodiesterases and cardiac cGMP: evolving roles and controversies | Q27692588 | ||
| Cyclic nucleotide phosphodiesterase (PDE) superfamily: A new target for the development of specific therapeutic agents | Q27991377 | ||
| Potency, selectivity, and consequences of nonselectivity of PDE inhibition | Q28269129 | ||
| Phosphodiesterases as therapeutic targets for Alzheimer's disease | Q28279704 | ||
| Characterization of a novel type of endogenous activator of soluble guanylyl cyclase | Q33208407 | ||
| A new simple cell-based homogeneous time-resolved fluorescence QRET technique for receptor-ligand interaction screening | Q33493817 | ||
| The fibrate gemfibrozil is a NO- and haem-independent activator of soluble guanylyl cyclase: in vitro studies | Q34042836 | ||
| Advances in targeting cyclic nucleotide phosphodiesterases | Q34139490 | ||
| Receptor guanylyl cyclase-G is a novel thermosensory protein activated by cool temperatures | Q35116614 | ||
| A constitutively activated mutant of human soluble guanylyl cyclase (sGC): implication for the mechanism of sGC activation | Q35234315 | ||
| Cobinamides are novel coactivators of nitric oxide receptor that target soluble guanylyl cyclase catalytic domain | Q35776824 | ||
| Cyclic guanosine monophosphate compartmentation in rat cardiac myocytes | Q35812341 | ||
| Explaining the phenomenon of nitrate tolerance | Q36272905 | ||
| Natriuretic peptides and nitric oxide stimulate cGMP synthesis in different cellular compartments. | Q36295757 | ||
| Cardiovascular cGMP-generating systems in physiological and pathological conditions. | Q36754532 | ||
| Guanylyl cyclase structure, function and regulation | Q36867727 | ||
| Biochemical Detection of cGMP From Past to Present: An Overview | Q37352774 | ||
| NO- and haem-independent soluble guanylate cyclase activators | Q37352787 | ||
| Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics | Q37420916 | ||
| Mammalian cyclic nucleotide phosphodiesterases: molecular mechanisms and physiological functions | Q37870035 | ||
| Nitrate therapy: new aspects concerning molecular action and tolerance | Q37876052 | ||
| Non-competitive aptamer-based quenching resonance energy transfer assay for homogeneous growth factor quantification. | Q38308502 | ||
| Quenching resonance energy transfer (QRET): a single-label technique for inhibitor screening and interaction studies | Q38365721 | ||
| The Potential of sGC Modulators for the Treatment of Age-Related Fibrosis: A Mini-Review | Q38991526 | ||
| Nitroglycerin and long-acting nitrates in clinical practice | Q40207524 | ||
| A cell-based cGMP assay useful for ultra-high-throughput screening and identification of modulators of the nitric oxide/cGMP pathway. | Q40446987 | ||
| Mechanisms of action of nitrates | Q40602825 | ||
| Activation of soluble guanylate cyclase causes relaxation of corpus cavernosum tissue: synergism of nitric oxide and YC-1. | Q40735472 | ||
| Development and validation of a transcreener assay for detection of AMP- and GMP-producing enzymes | Q41581326 | ||
| Disrupted nitric oxide signaling due to GUCY1A3 mutations increases risk for moyamoya disease, achalasia and hypertension. | Q41637594 | ||
| Regulation of soluble guanylyl cyclase redox state by hydrogen sulfide | Q42361109 | ||
| Functional characterization of nitric oxide and YC-1 activation of soluble guanylyl cyclase: structural implication for the YC-1 binding site? | Q42458596 | ||
| A real-time fluorescent assay of the purified nitric oxide receptor, guanylyl cyclase | Q42469883 | ||
| Cyclic Nucleotide (cAMP and cGMP) Assays and Capture ELISA for Quantitative Analysis of Plasmodium falciparum Blood-stage Egress | Q42641236 | ||
| Comparison of homogeneous single-label fluorometric binding assays: fluorescence polarization and dual-parametric quenching resonance energy transfer technique | Q42644653 | ||
| Phosphodiesterase inhibitors. Part 1: Synthesis and structure-activity relationships of pyrazolopyridine-pyridazinone PDE inhibitors developed from ibudilast | Q42741398 | ||
| In vitro activation of soluble guanylyl cyclase and nitric oxide release: a comparison of NO donors and NO mimetics | Q43691581 | ||
| Cyclic nucleotide signaling changes associated with normal aging and age-related diseases of the brain. | Q45305673 | ||
| A novel method for determination of the affinity of protein: protein interactions in homogeneous assays | Q46484655 | ||
| Development of a spectrophotometric assay for cyclase activity. | Q46805033 | ||
| High-Throughput Dual Screening Method for Ras Activities and Inhibitors. | Q48044552 | ||
| GTP-specific fab fragment-based GTPase activity assay | Q56890979 | ||
| Pharmacological manipulation of cGMP and NO/cGMP in CNS drug discovery | Q58603529 | ||
| Methylxanthine inhibitors of phosphodiesterases | Q69037510 | ||
| Expression of an active, monomeric catalytic domain of the cGMP-binding cGMP-specific phosphodiesterase (PDE5) | Q73212005 | ||
| Homogeneous single-label biochemical Ras activation assay using time-resolved luminescence | Q82585516 | ||
| A homogeneous single-label time-resolved fluorescence cAMP assay | Q83462189 | ||
| A homogeneous quenching resonance energy transfer assay for the kinetic analysis of the GTPase nucleotide exchange reaction | Q87741687 | ||
| Measurement of cGMP-generating and -degrading activities and cGMP levels in cells and tissues: Focus on FRET-based cGMP indicators | Q88442866 | ||
| Influence of riociguat treatment on pulmonary arterial hypertension : A meta-analysis of randomized controlled trials | Q89543096 | ||
| Phosphodiesterase inhibitors say NO to Alzheimer's disease | Q90179690 | ||
| Soluble Guanylate Cyclase Stimulators and Activators | Q91248952 | ||
| High-throughput amenable fluorescence-assays to screen for calmodulin-inhibitors | Q92067508 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 17469 | |
| P577 | publication date | 2020-10-15 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Homogeneous single-label cGMP detection platform for the functional study of nitric oxide-sensitive (soluble) guanylyl cyclases and cGMP-specific phosphodiesterases | |
| P478 | volume | 10 |
Search more.